I think the Aspire and Aruda shares were long sinc
Post# of 72440
There is no way that the selling of even millions of shares over two years accounts for this share price. The market cap is less than that of pre-clinical companies with only one class of drug in development, rather than 3 different drugs with multiple applications that are in thus-far successful clinical trials.
Having watched the tape go by on many occasions, it is clear that there has been a pattern of manipulation of stock price. Because the behavior of the trades during the day has suddenly changed, I think that there has been considerable short covering, and that the stock is poised for a move up. Also, the appearance of former bashers now attempting to pump the stock, or claiming always to have been bullish, indicates that at least one of the small-traders' gangs has changed sides.
In any case, I have utter confidence in the science, and I believe that when the move upward comes (which I don't expect until the fall, but of course I know nothing more than any other investor does), it will be shocking in its magnitude. Hopefully it will destroy any remaining short sellers when it does.